Skip to main content

Table 7 Proportions of fluoroquinolone resistance stratified by age groups

From: Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study

 

15–34

35–59

≥60

Total

p-value

Non-multidrug-resistance TB

692 (100.0%)

1512 (100.0%)

2034 (100.0%)

4238 (100.0%)

 

 Resistance to any FQa

5 (0.7%)

15 (1.0%)

19 (0.9%)

39 (0.9%)

0.824

 Ofx resistance

4 (0.6%)

15 (1.0%)

18 (0.9%)

37 (0.9%)

0.623

 Lfx resistance

5 (0.7%)

15 (1.0%)

19 (0.9%)

39 (0.9%)

0.824

 Mfx resistance

4 (0.6%)

12 (0.8%)

17 (0.8%)

33 (0.8%)

0.798

Multidrug-resistance TB

42 (100.0%)

81 (100.0%)

56 (100.0%)

179 (100.0%)

 

 Resistance to any FQa

11 (26.2%)

14 (17.3%)

11 (19.6%)

36 (20.1%)

0.502

 Ofx resistance

11 (26.2%)

12 (14.8%)

11 (19.6%)

34 (19.0%)

0.309

 Lfx resistance

10 (23.8%)

13 (16.0%)

11 (19.6%)

34 (19.0%)

0.576

 Mfx resistance

10 (23.8%)

10 (12.3%)

11 (19.6%)

31 (17.3%)

0.241

  1. Abbreviations: TB tuberculosis, FQ fluoroquinolone, Ofx ofloxacin, Lfx levofloxacin, Mfx moxifloxacin
  2. aAny fluoroquinolones refer to levofloxacin, moxifloxacin, or ofloxacin